Accuracy of leukocyte alkaline phosphatase score to predict JAK2 V617F mutation

被引：7
作者：
Basquiera, Ana L.
Fassetta, Fernanda
Soria, Nestor
Barral, Jose Moreno
Ricchi, Brenda
Garcia, Juan J.
机构：
[1] Hosp Privado Ctr Med Cordoba, Dept Hematol & Oncol, RA-5016 Cordoba, Argentina
[2] Univ Nacl Cordoba, Ctr Piloto Detecc Errores Metab, RA-5000 Cordoba, Argentina
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷 / 05期
关键词：
LAP; JAK2; myeloproliferative disorders; sensitivity; specificity;
D O I：
10.3324/haematol.10991
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Granulocyte activation parameters have been described in patients with myeloproliferative disorders (MPD). We have evaluated the accuracy of leukocyte alkaline phosphatase (LAP) score to predict JAK2 V617F mutation. LAP score was obtained using a cytochemical reaction in granulocytes of patients' peripheral blood with MPD.
引用
收藏
页码：704 / 705
页数：2
相关论文
共 10 条
[1]   Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders [J].
Baxter, EJ ;
Scott, LM ;
Campbell, PJ ;
East, C ;
Fourouclas, N ;
Swanton, S ;
Vassiliou, GS ;
Bench, AJ ;
Boyd, EM ;
Curtin, N ;
Scott, MA ;
Erber, WN ;
Green, AR .
LANCET, 2005, 365 (9464) :1054-1061
[2]  
BERLIN NI, 1975, SEMIN HEMATOL, V12, P339
[3]   Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status:: a prospective study [J].
Campbell, PJ ;
Scott, LM ;
Buck, G ;
Wheatley, K ;
East, CL ;
Marsden, JT ;
Duffy, A ;
Boyd, EM ;
Bench, AJ ;
Scott, MA ;
Vassiliou, GS ;
Milligan, DW ;
Smith, SR ;
Erber, WN ;
Bareford, D ;
Wilkins, BS ;
Reilly, JT ;
Harrison, CN ;
Green, AR .
LANCET, 2005, 366 (9501) :1945-1953
[4]  
Falanga A, 2000, BLOOD, V96, P4261
[5]   A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera [J].
James, C ;
Ugo, V ;
Le Couédic, JP ;
Staerk, J ;
Delhommeau, F ;
Lacout, C ;
Garçon, L ;
Raslova, H ;
Berger, R ;
Bennaceur-Griscelli, A ;
Villeval, JL ;
Constantinescu, SN ;
Casadevall, N ;
Vainchenker, W .
NATURE, 2005, 434 (7037) :1144-1148
[6]   A HISTOCHEMICAL PROCEDURE FOR LOCALIZING AND EVALUATING LEUKOCYTE ALKALINE PHOSPHATASE ACTIVITY IN SMEARS OF BLOOD AND MARROW [J].
KAPLOW, LS .
BLOOD, 1955, 10 (10) :1023-1029
[7]   The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera [J].
Lippert, Eric ;
Boissinot, Marjorie ;
Kralovics, Robert ;
Girodon, Francois ;
Dobo, Irene ;
Praloran, Vincent ;
Boiret-Dupre, Nathalie ;
Skoda, Radek C. ;
Hermouet, Sylvie .
BLOOD, 2006, 108 (06) :1865-1867
[8]   Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders [J].
Passamonti, F ;
Rumi, E ;
Pietra, D ;
Della Porta, MG ;
Boveri, E ;
Pascutto, C ;
Vanelli, L ;
Arcaini, L ;
Burcheri, S ;
Malcovati, L ;
Lazzarino, M ;
Cazzola, M .
BLOOD, 2006, 107 (09) :3676-3682
[9]   Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia [J].
Scott, Linda M. ;
Scott, Mike A. ;
Campbell, Peter J. ;
Green, Anthony R. .
BLOOD, 2006, 108 (07) :2435-2437
[10]   The World Health Organization (WHO) classification of the myeloid neoplasms [J].
Vardiman, JW ;
Harris, NL ;
Brunning, RD .
BLOOD, 2002, 100 (07) :2292-2302
1